More than 18,000 patients globally had been treated with ALYFTREK. Reimbursement had been secured in 31 countries outside the United States, reflecting the therapy’s international market access.
Key facts
Vertex ALYFTREK generated $706 million in worldwide Q3 2026 sales. source
Vertex ALYFTREK US year-to-date sales surpassed $1 billion. source
Vertex ALYFTREK had reimbursement in 31 countries outside the US. source
More than 18,000 patients globally had been treated with Vertex ALYFTREK. source